Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Registrati

Quotazioni in diretta

IPSC Century Therapeutics Inc

1,00

0,00 (0,00%)

Pre Mercato

Ultimo aggiornamento: 10:00:00

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

Date of Notice

08/05/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Adrienne Farid

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Century Therapeutics (NASDAQ:IPSC)
Storico
Da Dic 2024 a Dic 2024

Clicca qui per i Grafici di Century Therapeutics

Grafico Azioni Century Therapeutics (NASDAQ:IPSC)
Storico
Da Dic 2023 a Dic 2024

Clicca qui per i Grafici di Century Therapeutics

Notizie Century Therapeutics Inc - IPSC

Form 8-K - Current report
Venerdì 13 Dicembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 6 Dicembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Martedì 26 Novembre 2024 (1 mese fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 5 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 5 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 8-K - Current report
Martedì 5 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martedì 5 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Martedì 5 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
Martedì 5 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Lunedì 4 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
Lunedì 4 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sabatp 26 Ottobre 2024 (2 mesi fa) • Edgar (US Regulatory)

Più Century Therapeutics Inc Articoli Notizie

BMO Covered Call Health ...

Republic of France

Societe Generale Effekten

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea